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Purpose: This study was undertaken to determine the
effects of intratracheal administration of endotoxin on
hyperoxia-induced lung injury in neonatal rats. Materials
and Methods: Newborn Sprague Dawley rat pups were
divided into four experimental groups: normoxia control
(NC), normoxia with endotoxin treatment (NE), hyperoxia
control (HC), and hyperoxia with endotoxin treatment (HE)
groups. In HC and HE, rat pups were subjected to 14 days
of hyperoxia (> 95% oxygen) within 12 hours after birth.
In endotoxin treated group (NE and HE), Escherichia coli
endotoxin (0.5 g in 0.03 μ mL of saline) was given
intratracheally at the 1st, 3rd and 5th postnatal day. Radial
alveolar count (RAC), mean linear intercept (MLI),
RAC/MLI ratios, and degree of fibrosis were measured to
assess the changes in lung morphology. Results: During the
research period, survival rates in both HC and HE were
notably reduced 7 days after endotoxin was administered,
but body weight gain was considerably reduced only in
HC. On day 14, significant arrest in alveolarization, as
evidenced by the decrease of RAC and RAC/MLI ratio and
increase of MLI as well as increased fibrosis, were noted
in HC. Although slight but significant arrest in alveolarization
and increased fibrosis score were observed in NE compared
to NC, the hyperoxia-induced lung damage observed in HC
was significantly improved in HE. Conclusion: This study
suggests that intratracheal administration of endotoxin
significantly attenuated hyperoxia-induced lung injury in
neonatal rats.
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INTRODUCTION
Bronchopulmonary dysplasia (BPD), a form of
chronic lung disease usually occurring in prema-
ture infants, is an important cause of mortality
and morbidity during the neonatal period with
few effective treatment.
1 Histopathologic charac-
teristics of BPD include airway injury, inflam-
mation, and parenchymal fibrosis.
2-4 The precise
mechanism of BPD has not yet been elucidated,
therefore, it was felt of necessity to better
understand its pathophysiologic mechanism to
develop therapeutic modality that can prevent
lung injury and consequently improve the pro-
gnosis of BPD.
Clinically, antenatal inflammation, diagnosed
by chorioamnionitis or by elevated cytokines in
amniotic fluid, is associated with increased risks
of preterm delivery and BPD.
5 Neonatal sepsis
and/or pneumonia also are known to be risk
factors of BPD.
6 However, chorioamnionitis has
been associated with decreased incidence of
respiratory distress syndrome
7 and improved
survival.
8 In experimental animals, lung inflamma-
tion can be produced by administering endotoxin,
a lipopolysaccharide component of Gram-negative
bacteria.
9,10 Intra-alveolar inflammatory cell recruit-
ment and/or reduced alveolar growth were
observed after intratracheal
11 or intraamniotic
endotoxin administration.
12 However, systemic
administration of endotoxin significantly protected
lungs against oxygen toxicity in neonatal rats.
13
Therefore, available data on the role of inflam-
mation due to infection in the development of
BPD remain dubious, and further studies are
needed to clarify this. This study was done to
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determine the effects of intratracheal administration
of endotoxin on hyperoxia-induced lung injury in
neonatal rats.
MATERIALS AND METHODS
Animals and study design
The experimental protocols described herein
were reviewed and approved by the Animal Care
and Use Committee of the Samsung Biomedical
Research Institute in Seoul, Korea. This study also
followed the institutional and National Institutes
of Health guidelines for laboratory animal care.
Timed pregnant Sprague Dawley rats were housed
in individual cages with free access to water and
laboratory chow, and pups were delivered
spontaneously. The experiment began within 12
hours after birth and was continued through
postnatal day 14.
Rat pups were divided into four experimental
groups: normoxia control group (NC, n = 21),
normoxia with endotoxin treatment group (NE,
n= 24), hyperoxia control group (HC, n = 46), and
hyperoxia with endotoxin treatment group (HE,
n= 48). Throughout the experiment, rat pups of
NC and NE were kept in standard cages with
nursing mother rat at room air, and pups of HC
and HE were kept in standard cages with mother
rat within 50 liter Plexiglas chamber in which
hyperoxia (> 95% oxygen concentration) was
maintained. Humidity was maintained at 50%,
and environmental temperature was maintained
at 22 - 24 . To avoid oxygen toxicity of nursing
mother rat, mother rats were rotated daily
between litters in normoxia groups and hyperoxia
groups.
Pups in NE and HE were injected with E. coli
endotoxin (0.5 g in 0.03 μ mL, Lipopolysaccharide,
LPS from Escherichia coli O55:B5; Sigma, St Louis,
Mo; 10mg) intratracheally at the 1st, 3rd and 5th
postnatal day. Rats were restrained on a board on
a fixed angle, neck was palpated to locate the
trachea, and 1 cc syringe with a 30-gauge needle
was introduced into the trachea for instillation of
endotoxin. Intratracheal location of the needle was
confirmed by withdrawal of air into the syringe
with minimal reflux of suspension back through
the nose. Air was pulsed after each liquid volume.
Pups in NC and HC received an equal volume of
normal saline administered in the same way.
Animals were returned to their dams after the
procedure, and there was no mortality associated
with the procedure.
Survival and body weight of rat pups in each
group were checked daily throughout the experi-
ment, and were sacrificed at postnatal day 14 after
intraperitoneal injection of ketamine (Yuhan
Corp., Seoul, Korea, 50 mg/kg).
Tissue preparation
After perfusion of the heart with normal saline,
lungs were fixed in situ at a constant inflation
pressure of 20 cm H2O and fixed overnight in 10%
buffered formalin. The fixed lung tissue was
embedded in paraffin wax after tissue processing.
Five m-thick sections were cut from the paraffin μ
block and stained with hematoxylin and eosin.
Images of each section were captured with Baumer
optronic digital camera through an Olympus BX40
microscope (Olympus optical co. Ltd., Tokyo,
Japan) and were saved as JPEG files.
Lung histopathology
Alveolarization was assessed by performing
radial alveolar counts (RAC), according to the
method of Emery and Mithal.
14,15 From the center
of the respiratory bronchiole, a perpendicular line
was drawn to the edge of the acinus (as defined
by a connective tissue septum or the pleura), and
the number of the septa intersected by this line
was counted.
The intra-alveolar distance was measured as the
mean linear intercept (MLI), obtained by dividing
the total length of lines drawn across the lung
section by the number of intercepts encountered,
as described by Cooney and Thurlbeck.
16 After
obtaining the RAC and MLI values, the RAC/MLI
ratio was calculated in each case.
Each successive lung field was individually
assessed for severity of interstitial fibrosis and
allotted a score 0 and 8, as described by Ashcroft
et al.
17 A minimum of 10 lung fields per section
was examined for each analysis.Jae Won Shim, et al.
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Statistical analyses
All data are presented as mean ± standard
deviation. Statistical comparison between each
group was performed by one-way analysis of
variance with Bonferroni’s correction. For com-
parison of survival curves, Kaplan-Meiyer analysis
was performed. A p-value of < 0.05 was considered
significant.
RESULTS
Mortality and body weight gain
At the end of the experiment (postnatal day 14),
exposure to oxygen groups significantly decreased
the survival rate (HC and HE, 48% and 58%,
respectively) compared to normoxia groups (NC
and NE, 89% and 75%, respectively) (Fig. 1).
Although birth weights were not different
between the four experimental groups, pups
nursed in hyperoxia alone (HC) showed signifi-
cant decrease in body weight compared to
normoxia groups (NC, NE) after postnatal day 7,
and this hyperoxia-induced decrease of body
weight was improved with endotoxin administra-
tion (Fig. 2).
Lung histopathology
Representative photomicrographs showing
histopathologic differences in each experimental
group are shown in Fig. 3. Morphometric analyses
revealed slight but significant decrease in RAC
and RAC/MLI ratio and increased fibrosis score
in NE compared to NC (Fig. 4, 5). Compared to
normoxia groups (NC, NE), RAC and RAC/MLI
ratio in HC were significantly decreased, whereas
MLI and fibrosis score were significantly increased.
These hyperoxia-induced lung morphometric ab-
normalities, however, were significantly attenuated
with endotoxin administration (HE).
DISCUSSION
The development of an appropriate animal
model that can simulate clinical BPD of premature
infants is essential for delineation of its patho-
physiologic mechanism. The saccular stage of the
newly born rat pup corresponds to the lung
developmental stage of premature infants at 25-28
weeks gestation
18 and alveolarization occurs
during the first 2 weeks after birth.
19 Hence, the
newborn rat pup model is a model very suitable
Fig. 1. Time course of survival in each experimental
group in 95% oxygen or room air for 14 days. Normoxia
control group (NC), normoxia with endotoxin treatment
group (NE), hyperoxia control group (HC), hyperoxia
with endotoxin treatment group (HE). Values represent
group means ± SD. *p < 0.05 vs NC.
Fig. 2. Time course of weight change of endotoxin
instillation and control group rat pups in > 95% oxygen or
room air for 14 days. Normoxia control group (NC),
normoxia with endotoxin treatment group (NE), hyperoxia
control group (HC), hyperoxia with endotoxin treatment
group (HE). Values represent group means ± SD. *p < 0.05
vs NC.Fig. 3. Representative light micrographs of lung of rat pups at postnatal day 14. (A) Lung structure of neonatal rats in
normoxia at day 14 (NC). Note prominent secondary alveolar septa formation. (B) Intratracheal instillation of endotoxin
(NE) shows less prominent secondary alveolar septa formation and slightly alveolar dilatation. (C) Hyperoxia causes distal
air space enlargement, and alveolar architecture is simplified (HC) and prominent fibrosis. (D) Intratracheal instillation of
endotoxin during hyperoxia (HE), significantly attenuated hyperoxia-induced lung injury (Hematoxylin-eosin stain, original
magnification × 100).
Fig. 4. Radial alveolar counts (A), mean linear intercepts (B),
and radial alveolar counts/mean linear intercepts ratio (C) at
postnatal day 14 in four treatment groups: normoxia control
group (NC), normoxia with endotoxin treatment group (NE),
hyperoxia control group (HC), hyperoxia with endotoxin
treatment group (HE). Columns are mean ± SD. *p < 0.05 vs
NC, p < 0.05 vs NE, p < 0.05 vs HC.
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for studying pathophysiologic mechanisms of
BPD. In the histopathologic study of the lung,
Husain et al.
20 reported that RAC, MLI, and their
ratios are simple and the most useful way of
studying acinar growth and development.
Oxidative stress to the immature lung is a well-
known risk factor for the development of BPD.
21-23
In the present study, prolonged exposure of
newborn rat pups to hyperoxia developed lung
injuries similar to those seen in human infants
with BPD,
2 exhibiting decreased alveolarization as
evidenced by decreased RAC, increased MLI
3 and
markedly increased fibrosis.
4
Mild arrest in alveolar growth that was
evidenced by a slight decrease in the RAC and
RAC/MLI ratio, and an increase in fibrosis was
also observed in the endotoxin treated normoxia
group (NE) compared to NC. These findings
strengthen the assumption that inflammation due
to infection can disrupt alveolar development in
preterm lung, causing histological changes similar
to BPD.
12,13,24,25 However, endotoxin administration
during hyperoxia (HE) significantly attenuated
hyperoxia-induced abnormalities, such as an
Fig. 5. Effect of hyperoxia and endotoxin on fibrosis
at post-natal day 14 rat lung. Top: representative
photomicrographs (× 400 magnification) for each con-
dition. Bottom: mean fibrosis scores of each group;
normoxia control group (NC), normoxia with endo-
toxin treatment group (NE), hyperoxia control group
(HC), hyperoxia with endotoxin treatment group
(HE). Values represent group means ± SD. *p < 0.05 vs
NC; p < 0.05 vs NE; p < 0.05 vs HC.Endotoxin for Hyperoxic Lung Injury
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increase in MLI and fibrosis score, decrease in
RAC, RAC/MLI ratio, and body weight. Taken
together, our data indicate that the friend or foe
simple dichotomy could not account for the com-
plex role of inflammation induced by endotoxin in
the pathogenesis of BPD.
Although hyperoxia-induced mortality in the
present study was not significantly improved,
growth retardation observed in HC was signifi-
cantly attenuated with endotoxin treatment (HE).
Growth retardation observed in HC might be
attributable to higher caloric requirements of rat
pups with more severe lung disease. More severe
pathologic findings and clinical symptoms of
BPD, such as dyspnea and tachypnea, in HC than
in HE support our speculation.
The precise mechanisms by which endotoxin
attenuates hyperoxia-induced lung injury are not
completely understood. The protective effects of
endotoxin might be attributable to a combination
of enhanced lung maturation,
26,27 increased antio-
xidants,
13,28 surfactant,
12,29,30,31 loss of L-selectin and
reduced neutrophils in the lung,
32 and increased
anti-inflammatory cytokines such as interleukin 11
and 13.
33
Significant attenuation of the hyperoxia-induced
lung injury with endotoxin treatment observed in
this study contradicts the results by Kohno et al.
who reported that the most remarkable emphy-
sematous changes were noted in endotoxin plus
hyperoxia group.
34 As 10-week old rats were used
in the above study compared to 1-day-old newborn
rat pups in this study, differences in the stage of
lung maturation might be responsible for these
discrepancies with endotoxin treatment.
In the present study, endotoxin was given
intratracheally. Since the protective effect has also
been observed against the hyperoxia-induced lung
injury with systemic (intraperitoneal) admini-
stration of endotoxin,
13 the protective effects of
endotoxin appear to be not influenced by the
routes of administration.
Despite such effects of endotoxin, low survival
rate was noted in HC and HE groups on day 14
of the study, and this could be explained by
relatively high death rate in the endotoxin-
administered groups (NE and HE) during the
earlier study period. It is highly likely that the
concentration of endotoxin was higher than that
used in earlier studies, and that there was some
leakage into the systemic circulation.
The results described herein led us to conclude
that the administration of endotoxin, a potent pro-
inflammatory mediator, significantly attenuated
hyperoxia-induced neonatal lung injury as
evidenced by improvement in the arrest of
alveolarization and in the increased fibrosis. These
findings do not support the assumption that
antenatal inflammation due to infection causes
BPD, instead suggesting some beneficial effects of
chorioamnionitis.
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